Anabolic agents to treat osteoporosis

Sharing is caring!

How can parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) be anabolic agents for treating osteoporosis?

Persistently elevated serum PTH levels (hyperparathyroidism) or PTHrP levels promote osteoclastic bone resorption, hypercalcemia, and bone loss. In contrast, intermittent daily pulses of exogenous PTH or PTHrP actually stimulate osteoblast differentiation, proliferation, and survival, resulting in osteoid formation and increased bone mass. They also decrease the production of the bone inhibiting protein, sclerostin, from osteocytes.

Sharing is caring!


Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top